Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?

Biotech companies Axsome Therapeutics and Moderna are both strong contenders in the healthcare sector, but for different reasons. Axsome is posting impressive revenue growth, while Moderna's vaccine market may be cooling, but its oncology pipeline holds significant potential.